DFFN VS TNON Stock Comparison

Performance

DFFN
10/100

DFFN returned -61.80% in the last 12 months. Based on SPY's performance of -8.71%, its performance is below average giving it a score of 10 of 100.

TNON
10/100

TNON returned -85.60% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

DFFN
75/100

1 analysts offer 12-month price targets for DFFN. Together, they have an average target of 0, the most optimistic target put DFFN at 0 within 12-months and the most pessimistic has DFFN at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

TNON

"Analyst Price Targets" not found for TNON

Technicals

DFFN
14/100

DFFN receives a 14 of 100 based on 14 indicators. 1 are bullish, 11 are bearish.

TNON
57/100

TNON receives a 57 of 100 based on 14 indicators. 7 are bullish, 5 are bearish.

Earnings

DFFN
10/100

DFFN has missed earnings 7 times in the last 20 quarters.

TNON
10/100

TNON has missed earnings 4 times in the last 20 quarters.

Profit

DFFN
10/100

Out of the last 20 quarters, DFFN has had 0 profitable quarters and has increased their profits year over year on 0 of them.

TNON
10/100

Out of the last 10 quarters, TNON has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

DFFN
48/100

DFFN has had a lower than average amount of volatility over the last 12 months giving it a score of 48 of 100.

TNON
38/100

TNON has had a lower than average amount of volatility over the last 12 months giving it a score of 37 of 100.

All score calculations are broken down here to help you make more informed investing decisions

DIFFUSION PHARMACEUTICALS INC Summary

Nasdaq / DFFN

Healthcare

Biotechnology

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

Tenon Medical, Inc. Common Stock Summary

Nasdaq / TNON

Healthcare

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Power up your portfolio